Recent studies found that in these cancers, the expression and activity of ADAR1 can be regulated by tumor-promoting proteins CPSF6 (cleavage and polyadenylation factor-6) and mutant RPL39 (ribosomal protein L39, A14V). Here, ADAR is linked to cancer.